News

Prestigious line-up of pharma, academia and SMEs aim to improve security in drug development process.

The ability to track the movements of single molecules has revealed how proteins on the surface of nerve cells control gates that turn chemical signals into electrical signals. The finding is a step forward in detailing mechanisms involved in neurological disease.

The Virtual Cell, or VCell as it's known, is a software platform, using VCell, a biologist can predict what happens when a certain drug encounters a filtration cell in the kidney, for example, or how a hemoglobin molecule in a red blood cell deals with a spike in carbon dioxide.

Synpromics was nominated on the strength of being the leader in gene control, improving human health by enabling safer, more effective cell and gene medicines through proprietary genomics, bioinformatics and intelligent data-driven design.

Office set to open by end of 2017, supports global business growth strategy.

The report, which may lead to new ways of understanding genetic diseases, appears on the cover of Cell.

New technique for modeling human leukemia in mice may aid drug discovery and clinical trials.

Rare benign tumors known as insulinomas contain a complicated wiring diagram for regeneration of insulin-producing human beta cells, which may hold the key to diabetes drug development.

Company seeks funding to build on successful research programmes and commercialise new products.

Nobel Prize in Chemistry Awarded for "developing Cryo-electron microscopy for the high-resolution structure determination of biomolecules in solution."